SAN DIEGO — Diplomat Specialty Pharmacy has signed an agreement with a provider of acquisition and management services for oral cancer drugs that the companies said would allow for better access to the drugs and related programs.
RainTree Oncology Services announced the agreement with Flint, Mich.-based Diplomat, saying it was building a network of community oncologists through which members will obtain drugs at contracted prices and that the agreement would improve access to clinical and medication management programs.
"We are honored to be chosen by RainTree to be their specialty pharmacy partner," Diplomat president and CEO Phil Hagerman said. "Working in close partnership with RainTree will facilitate enhanced services to RainTree physicians and improved outcomes for their patients. This model will secure access to complex oral oncolytics as well as implement drug-specific algorithms that will help mimic clinical trial efficacy."
Changes in healthcare economics have affected how community oncology practices operate, RainTree said, putting pressure on their ability to deliver services to patients. This, according to the company, can make acquisition and management of oral cancer drugs problematic because the drugs are expensive and often not fully reimbursed.